2016
DOI: 10.1001/jamaoncol.2016.2631
|View full text |Cite
|
Sign up to set email alerts
|

The Potential of Radiomic-Based Phenotyping in Precision Medicine

Abstract: Although imaging technology is already embedded in clinical practice for diagnosis, staging, treatment planning, and response assessment, the transition of these computational methods to the clinic has been surprisingly slow. This review outlines the promise of these novel technologies for precision medicine and the obstacles to clinical application.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
393
0
5

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 533 publications
(398 citation statements)
references
References 78 publications
0
393
0
5
Order By: Relevance
“…More recently, MR fingerprinting (MRF) 80 was introduced to advance the role of quantitative MRI by using pseudorandomized acquisition parameters. However, large-scale, high-quality benchmark datasets, including complete clinical labels, standard radiomic features, and molecular profiles are not widely available for the purpose of data sharing, experimental evaluation, and reproducibility of radiomics towards precision medicine 81, 82 .…”
Section: Research Opportunities and Challengesmentioning
confidence: 99%
“…More recently, MR fingerprinting (MRF) 80 was introduced to advance the role of quantitative MRI by using pseudorandomized acquisition parameters. However, large-scale, high-quality benchmark datasets, including complete clinical labels, standard radiomic features, and molecular profiles are not widely available for the purpose of data sharing, experimental evaluation, and reproducibility of radiomics towards precision medicine 81, 82 .…”
Section: Research Opportunities and Challengesmentioning
confidence: 99%
“…Change of the status quo may be met with antagonism, as evidenced by the resistance to transition from diagnostically useful genomics/proteomics platforms to analogously validated imaging methodologies. Also, considering the range of multiplexed-imaging methods currently in development, there is a striking lack of robust standardised methodology to permit data comparison across centres and enable exploitation for machine learning and other big data approaches for segmentation, registration, detection and heterogeneity determination 10 .…”
Section: Multiplexing For the Classification Of Cancer Phenotypesmentioning
confidence: 99%
“…In essence, this constitutes a way of achieving 'activatable' high LET radiotherapy. In a landmark study, BNCT using liposomal delivery of 10 B significantly reduced tumour growth in a preclinical EMT6 model of mammary adenocarcinoma 242 . As in EBT, beam positioning is a critical element in BNCT.…”
Section: Imaging and Radiotherapymentioning
confidence: 99%
“…These methods excel at identifying complex patterns in images and in using this information to guide clinical decisions (1)(2)(3). AI encompasses quantitative image analysis, also known as radiomics (4)(5)(6)(7)(8)(9), which involves either the application of predefined engineered algorithms (that often rely on input from expert radiologists) or the use of deep learning technologies that can automatically learn feature representations from example data (4). Consequently, AI is expected to play a key role in automating clinical tasks that presently can only be done by human experts (1,2).…”
Section: -4 ó2017 Aacrmentioning
confidence: 99%